Clinical Trial Update: A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer. [Phase 1]

View source ↗

Summary

A Phase 1 study intended to restore radioiodine sensitivity in advanced papillary thyroid carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillary Thyroid Carcinoma

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Papillary Thyroid Cancer | Phase 1 | Status: TERMINATED